BIB’s sister company, a large-scale CDMO integrated platform for biopharmaceuticals, held a groundbreaking ceremony for constructing its facility in Shanghai, China recently. The biopharmaceutical GMP production facility, with a total production capacity of 12,000 liters, will comply with PanFlexTM-Engineering high international standard. It is expected to be operational in June 2021.
Click to rate this post!
[Total: 0 Average: 0]